Cargando…

Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential

The development of efficient strategies for generating fully human monoclonal antibodies with unique functional properties that are exploitable for tailored therapeutic interventions remains a major challenge in the antibody technology field. Here, we present a methodology for recovering such antibo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diebolder, Philipp, Keller, Armin, Haase, Stephanie, Schlegelmilch, Anne, Kiefer, Jonathan D, Karimi, Tamana, Weber, Tobias, Moldenhauer, Gerhard, Kehm, Roland, Eis-Hübinger, Anna M, Jäger, Dirk, Federspil, Philippe A, Herold-Mende, Christel, Dyckhoff, Gerhard, Kontermann, Roland E, Arndt, Michaela AE, Krauss, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929437/ https://www.ncbi.nlm.nih.gov/pubmed/24256717 http://dx.doi.org/10.4161/mabs.27236

Ejemplares similares

Organerhalt: Entscheidungskriterien für Patienten mit T3-Larynxkarzinom
por: Dyckhoff, Gerhard, et al.
Publicado: (2022)

Larynxorganerhalt bis zum T4‑Larynxkarzinom?
por: Dyckhoff, Gerhard, et al.
Publicado: (2022)

Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma
por: Dyckhoff, Gerhard, et al.
Publicado: (2022)

Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients
por: Dyckhoff, Gerhard, et al.
Publicado: (2021)

Chemoradiotherapy but Not Radiotherapy Alone for Larynx Preservation in T3. Considerations from a German Observational Cohort Study
por: Dyckhoff, Gerhard, et al.
Publicado: (2021)

An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment
por: Dyckhoff, Gerhard, et al.
Publicado: (2021)

The making of bispecific antibodies
por: Brinkmann, Ulrich, et al.
Publicado: (2017)

Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics
por: Kontermann, Roland E., et al.
Publicado: (2021)

The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma
por: Rigalli, Juan Pablo, et al.
Publicado: (2018)

GlycoTAIL and FlexiTAIL as Half-Life Extension Modules for Recombinant Antibody Fragments
por: Seifert, Oliver, et al.
Publicado: (2022)

Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response
por: Sapski, Sabrina, et al.
Publicado: (2020)

Association of Drug Transporter Expression with Mortality and Progression-Free Survival in Stage IV Head and Neck Squamous Cell Carcinoma
por: Warta, Rolf, et al.
Publicado: (2014)

The eIg technology to generate Ig-like bispecific antibodies
por: Kühl, Lennart, et al.
Publicado: (2022)

Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigens
por: Alt, Mira, et al.
Publicado: (2018)

Case Report: Infection With SARS-CoV-2 in the Presence of High Levels of Vaccine-Induced Neutralizing Antibody Responses
por: Schulte, Bianca, et al.
Publicado: (2021)

A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells
por: Aschmoneit, Nadine, et al.
Publicado: (2021)

The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells
por: Dao Trong, Philip, et al.
Publicado: (2023)

Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity
por: Richter, Fabian, et al.
Publicado: (2013)

Back-to-Germline (B2G) Procedure for Antibody Devolution
por: Schrade, Anja, et al.
Publicado: (2019)

Coronavirus, humanpathogenes
por: Kehm, Roland
Publicado: (2009)

SARS-Coronavirus (SARS-CoV)
por: Kehm, Roland
Publicado: (2009)

Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
por: Silke Heilingloh, Christiane, et al.
Publicado: (2020)

Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer
por: Herr, Ingrid, et al.
Publicado: (2012)

Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models
por: Warwas, Karsten M., et al.
Publicado: (2021)

Sharing of heteroplasmies between human liver lobes varies across the mtDNA genome
por: Hübner, Alexander, et al.
Publicado: (2019)

A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells
por: Weber, Tobias, et al.
Publicado: (2015)

The impact of immunogenicity on therapeutic antibody pharmacokinetics: A preclinical evaluation of the effect of immune complex formation and antibody effector function on clearance
por: Opolka-Hoffmann, Eugenia, et al.
Publicado: (2021)

Large-Scale Drug Screening in Patient-Derived IDH(mut) Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents
por: Dao Trong, Philip, et al.
Publicado: (2020)

MetaboDiff: an R package for differential metabolomic analysis
por: Mock, Andreas, et al.
Publicado: (2018)

8(th) Annual European Antibody Congress 2012: November 27–28, 2012, Geneva, Switzerland
por: Beck, Alain, et al.
Publicado: (2013)

Opportunistic Infections with Coronavirus-Like Particles in Patients Infected with the Human Immunodeficiency Virus?
por: Eis-Hübinger, A.M., et al.
Publicado: (1989)

CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins
por: Jost, Christian, et al.
Publicado: (2020)

Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody
por: Krawczyk, Adalbert, et al.
Publicado: (2015)

A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients
por: Dyckhoff, Gerhard, et al.
Publicado: (2017)

Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT
por: Jungwirth, Gerhard, et al.
Publicado: (2019)

A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3
por: Rau, Alexander, et al.
Publicado: (2021)

A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease
por: Bauer, Dirk, et al.
Publicado: (2017)

L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach
por: Silveira, Cássia G. T., et al.
Publicado: (2013)

Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
por: Salnikov, Alexei V, et al.
Publicado: (2009)

Basic research on herpes simplex viruses: are mutants still needed?
por: Matz, Bertfried, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dab347715st0rlmavr055rs05i